CheckMan Stock Market Overview

TM's U.S. sales edge higher in Q3, fueled by a 28.5% jump in electrified vehicle deliveries, which account for 57.4% of total sales.

J&J's diversified portfolio, new drug launches and sales growth give it an edge despite Pfizer's cheaper valuation and higher yield.

Buy now pay later lenders are rallying as a group, and Affirm Holdings (NASDAQ:AFRM | AFRM Price Prediction) leads a cohort climbing in step while the wider financials sector barely moves. Affirm stock is changing hands at $74.

NEW YORK, Oct. 05, 2026 (GLOBE NEWSWIRE) -- A roughly 8% after-hours slide in FICO (NYSE: FICO) stock deepened to a reported 20% premarket drop after the Federal Housing Finance Agency announced it would simplify mortgage pricing and could allow a direct competitor to FICO's credit score into mortgage underwriting. If you held FICO shares through that overnight selloff and lost money, you may have legal rights.

RARE's gene therapy for Sanfilippo syndrome wins EMA validation, advancing the treatment toward formal review in Europe.

CRDO's AI-driven growth, expanding optics portfolio and strong margins support its outlook, but premium valuation and execution risks warrant caution.

SNEX's Integra deal strengthens its Colombian coffee platform and expands its physical commodities capabilities.

UnitedHealth is exiting select Medicare Advantage plans for 2027 as rising medical costs pressure profitability, reshaping its membership mix.

Costco cuts prices on Kirkland Signature staples, using tariff refunds and private-label flexibility to reinforce affordability and member value.

RL's women's apparel, outerwear and handbags increased by more than 20%, outpacing overall growth and highlighting further category potential.